ASSEMBLY BIOSCIENCES, INC. (ASMB)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Collaboration revenue from a related party | 9,626 | 9,419 | 6,845 | |
| Research and development | 16,125 | 14,851 | 13,515 | |
| General and administrative | 4,594 | 4,509 | 4,286 | |
| Total operating expenses | 20,719 | 19,360 | 17,801 | |
| Loss from operations | -11,093 | -9,941 | -10,956 | |
| Interest and other income, net | 895 | 1,123 | 1,343 | |
| Total other income | 895 | 1,123 | 1,343 | |
| Loss before income taxes | -10,198 | - | -9,613 | |
| Income tax expense | - | - | - | |
| Net loss | -10,198 | -8,818 | -9,613 | |
| Unrealized loss on marketable debt securities | -26 | -42 | 137 | |
| Comprehensive loss | -10,224 | -8,860 | -9,476 | |
| Earnings per share, basic | -1.33 | -1.17 | -1.51 | |
| Earnings per share, diluted | -1.33 | -1.17 | -1.51 | |
| Weighted average number of shares outstanding, basic | 7,655,854 | 7,506,321 | 6,351,431 | |
| Weighted average number of shares outstanding, diluted | 7,655,854 | 7,506,321 | 6,351,431 | |